Genmab in potential million-dollar-deal with US company
The Danish company Genmab has signed a new deal for a potential value of hundreds of millions of dollars, according to which they will supply antibodies to an American biotech company.
If things work out, the Danish company Genmab could earn just about a billion Danish kroner from the recently signed deal with the US company Janssen Biotech.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
